Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1866359

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1866359

Global Consumer DNA (Genetic) Testing Market - Forecasts from 2025 to 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multiple User License)
USD 4550
PDF (Enterprise License)
USD 6950

Add to Cart

The Global Consumer DNA (Genetic) Testing Market will soar from USD 1,813.099 million in 2025 to USD 3,161.211 million in 2030, with an 11.76% compound annual growth rate (CAGR).

The global consumer DNA (genetic) testing market is experiencing accelerated growth, propelled by escalating demand for direct-to-consumer (DTC) services, identity exploration, and ancestry insights. These tests analyze chromosomal, genetic, and protein variations to assess disease risks, rule out conditions, or uncover familial heritage. Key drivers include heightened public awareness of technological advancements and substantial investments by leading firms in innovative DTC solutions. Major players like Ancestry and 23andMe are channeling resources into superior testing platforms, enhancing accuracy and user accessibility. The expansion of genetic ancestry testing, which extends beyond historical records to reveal deep genealogical connections via cheek swabs or saliva kits, is a pivotal force. This segment's appeal lies in its entertainment value and potential for discovering hidden family ties, fostering broader market penetration.

Market Drivers

Surge in Genetic Ancestry Testing

Genetic ancestry testing represents a cornerstone of market expansion, enabling individuals to trace lineage and ethnic origins with unprecedented precision. Demand has surged particularly in Europe and North America, where consumers seek affordable, at-home kits priced competitively to democratize access. These tests, often costing around US$59, deliver comprehensive reports on heritage, migration patterns, and relative matches, transforming personal curiosity into actionable insights. Leading providers maintain vast DNA databases, aggregating millions of profiles to refine matching algorithms and expand reference populations. For instance, Ancestry and 23andMe boast some of the world's largest human DNA repositories, facilitating robust ethnicity estimates and family tree integrations.

The DTC model's growth amplifies this trend, empowering users to bypass clinical settings for immediate results. Companies like Gene By Gene and MyHeritage contribute through expansive ancestry databases-encompassing millions of profiles-supporting advanced features such as high-resolution geographic subgrouping across thousands of regions. This innovation not only boosts user engagement but also enhances market share by offering personalized, scientifically grounded narratives. The merger dynamics among genomics firms, such as those involving myDNA and FamilyTreeDNA, underscore a strategic focus on bolstering scientific foundations for tailored insights, integrating DTC with professional-grade analytics. Such developments signal a maturing ecosystem where ancestry testing intersects with health and wellness applications, driving cross-selling opportunities and sustained revenue growth.

Geographical Outlook

The Asia-Pacific region is poised to capture a substantial market share, fueled by a proliferation of startups and burgeoning enthusiasm for ancestral DNA exploration. Rapid urbanization, rising disposable incomes, and cultural interest in heritage tracing are accelerating adoption, positioning the region as a high-growth hub. This contrasts with established markets in Europe and North America, where mature infrastructure supports premium services, but Asia-Pacific's scalability offers untapped potential for global players.

Market Outlook

The consumer DNA testing market is on a trajectory of robust expansion through 2030, with genetic ancestry as a linchpin for innovation and consumer adoption. Affordable, user-centric kits and expansive databases will continue to lower barriers, while DTC evolution integrates ancestry with predictive health analytics. Industry experts should monitor regulatory shifts around data privacy and ethical sourcing to mitigate risks. Strategic investments in AI-driven interpretations and regional partnerships will be essential to capitalize on Asia-Pacific's momentum, ensuring sustained differentiation in a competitive landscape dominated by data-rich incumbents.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Type

  • Carrier Testing
  • Ancestry Testing
  • Predictive Testing
  • Others

By Sample Type

  • Saliva
  • Cheek Swab
  • Others

By Distribution Channel

  • Online
  • Offline

By Application

  • Kinship
  • Ancestry & Genealogy
  • Health & Wellness Testing
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others
Product Code: KSI061611330

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Carrier Testing
  • 5.3. Ancestry Testing
  • 5.4. Predictive Testing
  • 5.5. Others

6. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY SAMPLE TYPE

  • 6.1. Introduction
  • 6.2. Saliva
  • 6.3. Cheek Swab
  • 6.4. Others

7. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Online
  • 7.3. Offline

8. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY DISTRIBUTION CHANNEL

  • 8.1. Introduction
  • 8.2. Kinship
  • 8.3. Ancestry & Genealogy
  • 8.4. Health & Wellness Testing
  • 8.5. Others

9. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Quest Diagnostics Inc.
  • 11.2. Mapmygenome
  • 11.3. Labcorp
  • 11.4. Gene by Gene, Ltd
  • 11.5. Myriad Genetics
  • 11.6. Color Health Inc.
  • 11.7. 23andMe Inc.
  • 11.8. Ancestry
  • 11.9. Veritas Genetics
  • 11.10. Nebula Genomics

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!